Bullish & Foolish
Full CNXU fundamentals All 466 on the Survival Watch

CNXUCONEXEU SCIENCES INC.

Is Conexeu Sciences struggling financially?

Yes, by its own account. Conexeu Sciences told the SEC on 15 Jun 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Jun 2026

0/100

Critical

Sector
Biotech/Pharma
Market cap
$237.9M
Source filing
10-Q 15 Jun 2026
Balance sheet
30 Apr 2026

Cash runway

Not estimable

The latest filings do not carry the cash or cash-flow lines needed to estimate a runway. Publishing a number here would mean inventing one.

What it reported

Cash and short-term investments

$6.8M

What Conexeu Sciences told the SEC

…As of April 30, 2026, and October 31, 2025, the Company had an accumulated deficit of $ 8,544,626 and $ 4,521,520 , respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of these unaudited condensed interim financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the…

CONEXEU SCIENCES INC., Form 10-Q, filed 15 Jun 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 123.9% share-count increase The company issued stock. Each share now owns 55.3% less of the business than a year ago, before any change in the price.

Other Biotech/Pharma companies that filed the doubt